Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    7661914 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Intravenous Immunoglobulins as Effective Treatment in Sydenham's Chorea
Conditions: Sydenham Chorea;   Post Streptococcal Movement Disorder
Interventions: Biological: Intravenous immunoglobulin;   Drug: standard interventions penicillin VK and haloperidol
2 Completed Treatment of Childhood Onset Psychiatric Disorders With Intravenous Immunoglobulin (IVIg)
Conditions: Autoimmune Diseases;   Mental Disorders Diagnosed in Childhood;   Schizophrenia
Intervention: Drug: Intravenous immunoglobulin

Indicates status has not been verified in more than two years